Insider Market Sense
  • Politics
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick
Editor's PickStock

30 Dow Stocks in 20 Minutes: Joe Rabil’s Mid-Year Technical Check

by July 16, 2025
July 16, 2025

This week, Joe analyzes all 30 Dow Jones Industrial Average stocks in a rapid-fire format, offering key technical takeaways and highlighting potential setups in the process. Using his multi-timeframe momentum and trend approach, Joe shows how institutional investors assess relative strength, chart structure, ADX signals, and support zones. From Boeing’s triple bottom to Nvidia’s powerful trend, not to mention Microsoft’s key pullback level, this session is packed with insights for traders looking to stay in sync with the market’s leaders and laggards.

Joe has been working with institutional portfolio managers for the past 35 years, and this video shows the type of reads he gives to them during their phone calls.

The video premiered on July 16, 2025. Click this link to watch on Joe’s dedicated page. 

Archived videos from Joe are available at this link. Send symbol requests to stocktalk@stockcharts.com; you can also submit a request in the comments section below the video on YouTube. Symbol Requests can be sent in throughout the week prior to the next show.

previous post
Clearing the Air on Particulate Matter Regulation
next post
Simpler Charts, Better Results? Use This Trick to Trade Smarter With Less

You may also like

Week Ahead: NIFTY Violates Short-Term Supports; Stays Tentative...

July 19, 2025

The Real Drivers of This Market: AI, Semis...

July 19, 2025

July Strength, Late-Summer Caution: 3 Charts to Watch

July 18, 2025

Three Stocks in Focus: One Old Favorite, One...

July 18, 2025

Don’t Hate the Player, Hate the Income Tax...

July 18, 2025

What Governor Beshear’s Comments Miss About Addiction and...

July 18, 2025

Friday Feature: Positive Tomorrows

July 18, 2025

Public Corruption and Federalism

July 18, 2025

June BLS Price Index Reports Do Not Support...

July 18, 2025

Who Deserves a Cure? The FDA’s New Gatekeeping...

July 18, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • About us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2024 InsiderMarketSense.com All Rights Reserved.

Insider Market Sense
  • Politics
  • Investing
  • Tech News
  • Stock
  • Editor’s Pick